CY1112201T1 - Φαρμακο για τη θεραπευτικη αγωγη γριπης - Google Patents
Φαρμακο για τη θεραπευτικη αγωγη γριπηςInfo
- Publication number
- CY1112201T1 CY1112201T1 CY20111101293T CY111101293T CY1112201T1 CY 1112201 T1 CY1112201 T1 CY 1112201T1 CY 20111101293 T CY20111101293 T CY 20111101293T CY 111101293 T CY111101293 T CY 111101293T CY 1112201 T1 CY1112201 T1 CY 1112201T1
- Authority
- CY
- Cyprus
- Prior art keywords
- medicine
- therapeutic
- active ingredient
- influenza
- prophylactic agent
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 206010064097 avian influenza Diseases 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007056872 | 2007-03-07 | ||
| EP08721158A EP2123271B1 (en) | 2007-03-07 | 2008-03-03 | Drug for treatment of influenza |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1112201T1 true CY1112201T1 (el) | 2015-12-09 |
Family
ID=39738201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111101293T CY1112201T1 (el) | 2007-03-07 | 2011-12-30 | Φαρμακο για τη θεραπευτικη αγωγη γριπης |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20100204314A1 (zh) |
| EP (1) | EP2123271B1 (zh) |
| JP (2) | JP5286251B2 (zh) |
| KR (1) | KR101473028B1 (zh) |
| CN (1) | CN101715343B (zh) |
| AT (1) | ATE526960T1 (zh) |
| CA (1) | CA2680415A1 (zh) |
| CY (1) | CY1112201T1 (zh) |
| DK (1) | DK2123271T3 (zh) |
| ES (1) | ES2372996T3 (zh) |
| HK (1) | HK1137142A1 (zh) |
| HR (1) | HRP20110861T1 (zh) |
| PL (1) | PL2123271T3 (zh) |
| PT (1) | PT2123271E (zh) |
| SI (1) | SI2123271T1 (zh) |
| TW (1) | TWI424841B (zh) |
| WO (1) | WO2008108323A1 (zh) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| EP2318832B1 (en) | 2008-07-15 | 2013-10-09 | Academia Sinica | Glycan arrays on ptfe-like aluminum coated glass slides and related methods |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| EP2568976B1 (en) | 2010-05-10 | 2015-09-30 | Academia Sinica | Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses |
| CN104926802B (zh) * | 2011-12-16 | 2018-02-13 | 第一三共株式会社 | 用于制备神经氨酸衍生物的方法 |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| JP6302909B2 (ja) | 2012-08-18 | 2018-03-28 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | シアリダーゼの同定および画像化のための細胞透過性プローブ |
| EP3013365B1 (en) | 2013-06-26 | 2019-06-05 | Academia Sinica | Rm2 antigens and use thereof |
| US9981030B2 (en) | 2013-06-27 | 2018-05-29 | Academia Sinica | Glycan conjugates and use thereof |
| AU2014317889B2 (en) | 2013-09-06 | 2020-03-05 | Academia Sinica | Human iNKT cell activation using glycolipids with altered glycosyl groups |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| WO2015109180A2 (en) | 2014-01-16 | 2015-07-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| WO2015148915A1 (en) | 2014-03-27 | 2015-10-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
| JP6894239B2 (ja) | 2014-05-27 | 2021-06-30 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | 増強された抗体の有効性のための普遍的グリコフォームに関する組成物および方法 |
| CA2950415A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-cd20 glycoantibodies and uses thereof |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| EP3149037A4 (en) | 2014-05-27 | 2018-01-10 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
| EP3154582A4 (en) | 2014-05-28 | 2018-01-10 | Academia Sinica | Anti-tnf-alpha glycoantibodies and uses thereof |
| WO2016040369A2 (en) | 2014-09-08 | 2016-03-17 | Academia Sinica | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| EP3248005B1 (en) | 2015-01-24 | 2020-12-09 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| TW201808978A (zh) | 2016-03-08 | 2018-03-16 | 中央研究院 | N-聚醣及其陣列之模組化合成方法 |
| WO2018039274A1 (en) | 2016-08-22 | 2018-03-01 | CHO Pharma Inc. | Antibodies, binding fragments, and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451766B1 (en) * | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| JP3209946B2 (ja) * | 1996-07-22 | 2001-09-17 | 三共株式会社 | ノイラミン酸誘導体 |
| US6340702B1 (en) | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| PT823428E (pt) * | 1996-07-22 | 2002-04-29 | Sankyo Co | Derivados do acido neuraminico sua preparacao e sua utilizacao em medicina |
| JP4151800B2 (ja) | 1996-08-13 | 2008-09-17 | 第一三共株式会社 | ノイラミン酸化合物 |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| JP3920041B2 (ja) * | 2000-04-25 | 2007-05-30 | 三共株式会社 | ノイラミン酸化合物の水和物及び結晶 |
| ATE414215T1 (de) | 2005-08-22 | 2008-11-15 | Delphi Tech Inc | Nockenwellenversteller zur einstellung der phase zwischen einer nockenwelle und einem antriebsrad |
-
2008
- 2008-03-03 AT AT08721158T patent/ATE526960T1/de active
- 2008-03-03 CN CN2008800149108A patent/CN101715343B/zh active Active
- 2008-03-03 US US12/449,909 patent/US20100204314A1/en not_active Abandoned
- 2008-03-03 EP EP08721158A patent/EP2123271B1/en not_active Not-in-force
- 2008-03-03 CA CA002680415A patent/CA2680415A1/en not_active Abandoned
- 2008-03-03 PL PL08721158T patent/PL2123271T3/pl unknown
- 2008-03-03 JP JP2009502568A patent/JP5286251B2/ja active Active
- 2008-03-03 DK DK08721158.7T patent/DK2123271T3/da active
- 2008-03-03 SI SI200830440T patent/SI2123271T1/sl unknown
- 2008-03-03 KR KR1020097018422A patent/KR101473028B1/ko active IP Right Grant
- 2008-03-03 WO PCT/JP2008/053738 patent/WO2008108323A1/ja active Application Filing
- 2008-03-03 ES ES08721158T patent/ES2372996T3/es active Active
- 2008-03-03 PT PT08721158T patent/PT2123271E/pt unknown
- 2008-03-07 TW TW097107984A patent/TWI424841B/zh active
-
2010
- 2010-04-21 HK HK10103858.3A patent/HK1137142A1/xx unknown
-
2011
- 2011-11-21 HR HR20110861T patent/HRP20110861T1/hr unknown
- 2011-12-30 CY CY20111101293T patent/CY1112201T1/el unknown
-
2013
- 2013-04-22 JP JP2013089202A patent/JP6012076B2/ja active Active
- 2013-08-27 US US14/010,784 patent/US20140018418A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP6012076B2 (ja) | 2016-10-25 |
| ATE526960T1 (de) | 2011-10-15 |
| US20100204314A1 (en) | 2010-08-12 |
| EP2123271A4 (en) | 2010-03-17 |
| WO2008108323A1 (ja) | 2008-09-12 |
| KR101473028B1 (ko) | 2014-12-15 |
| CN101715343A (zh) | 2010-05-26 |
| HK1137142A1 (en) | 2010-07-23 |
| US20140018418A1 (en) | 2014-01-16 |
| DK2123271T3 (da) | 2012-01-23 |
| CA2680415A1 (en) | 2008-09-12 |
| PL2123271T3 (pl) | 2012-03-30 |
| TWI424841B (zh) | 2014-02-01 |
| TW200848018A (en) | 2008-12-16 |
| EP2123271A1 (en) | 2009-11-25 |
| JP2013139483A (ja) | 2013-07-18 |
| EP2123271B1 (en) | 2011-10-05 |
| JPWO2008108323A1 (ja) | 2010-06-17 |
| HRP20110861T1 (hr) | 2011-12-31 |
| SI2123271T1 (sl) | 2012-05-31 |
| JP5286251B2 (ja) | 2013-09-11 |
| CN101715343B (zh) | 2012-09-26 |
| ES2372996T3 (es) | 2012-01-30 |
| PT2123271E (pt) | 2011-12-20 |
| KR20090129414A (ko) | 2009-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112201T1 (el) | Φαρμακο για τη θεραπευτικη αγωγη γριπης | |
| CY1124357T1 (el) | Προσδιορισμος ανισορροπιας αλληλουχιας νουκλεϊκων οξεων | |
| EA202090255A2 (ru) | 6,7-дигидро-5h-бензо[7]аннуленовые производные в качестве модуляторов эстрогеновых рецепторов | |
| CY1115738T1 (el) | Κρυσταλλικα επιδιαλυτωμενα συμπλοκα των παραγωγων (1s)-1,5-anyδpo-1-c-(3-((φainyλ)meθυλ) φαινυλ)-d-γλουσιτολης με αλκοολες οπως αναστολεις sglt2 για τη θεραπευτικη αντιμετωπιση του διαβητη | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| CY1117080T1 (el) | Θεραπευτικος παραγοντας για στενωση του σπονδυλικου σωληνα | |
| EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
| BR112014003237A2 (pt) | compostos de indazol, composições e métodos de uso | |
| ATE473975T1 (de) | Chemische verbindungen | |
| ATE398613T1 (de) | Chemische verbindungen | |
| SMP201100019B (it) | Composti organici | |
| CY1117085T1 (el) | C7-φθορο υποκατεστημενες ενωσεις τετρακυκλινης | |
| MA37142A3 (fr) | Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine | |
| CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
| MA32192B1 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
| EA201170237A1 (ru) | Производные карбаматов алкилтиазолов, их получение и их применение в терапии | |
| BRPI0813809A2 (pt) | derivados de 7-alquinil -1,8-naftiridonas, sua preparação e sua aplicação em terapêutica. | |
| HK1081194A1 (en) | 6-amino-1h-indazole compounds as phosphodiesterase4 inhibitors, pharmaceutical compositions compris ing the same, and use thereof | |
| CY1115729T1 (el) | Τρικυκλικη ενωση και φαρμακευτικη χρηση αυτης | |
| UY30788A1 (es) | Compuestos quimicos | |
| EA200800149A1 (ru) | 4,5-диарилпиррольные производные, способ их получения и применение в терапии | |
| TW200745048A (en) | Novel benzimidazole and benzothiazole derivatives, preparation process therefor, application thereof as medicaments, pharmaceutical compositions and novel use especially as CMET inhibitors | |
| EA200970497A1 (ru) | Производные пиррола, их получение и их применение в терапии | |
| EA200700179A1 (ru) | Производные пиррола, их получение и их применение в терапии | |
| MA32527B1 (fr) | Derives 6-heterocyclique -imidazo[1,2-a]pyrroine-2-carboxamides, leur preparation et leur application en therapeutique |